Crystal structure, theoretical and experimental electronic structure and DNA/BSA protein interactions of nickel(II) N2O2 tetradentate Schiff base complexes

A Water-Soluble Schiff Base Turn-on Fluorescent Chemosensor for the Detection of Al3+ and Zn2+ Ions at the Nanomolar Level: Application in Live-Cell Imaging

A water-soluble Schiff base, 2,3-bis((E)-(2-hydroxy-3-methoxybenzylidene)amino) propanoic acid (ODA) prepared by condensing o-vanillin and DL-2,3-diaminopropionic acid was evaluated as an efficient "turn on" fluorescent chemosensor for the selective recognition of Al3+ and Zn2+ ions in presence of several interfering metal ions (detection limit; for Al3+ = 1.82 nM, Zn2+ = 7.06 nM). The probe also shows a selective chromogenic behavior towards Al3+ and Zn2+ ions that the naked eye can view. The binding stoichiometry was determined using 1H-NMR titration and ESI-MS spectrometry. The sensing mechanism is due to the inhibition of ESIPT and isomerization of -C=N of ODA on complexation with Al3+/Zn2+. The intramolecular hydrogen bonding energy and the critical bond energy in ODA-Al3+/Zn2+ were calculated using QTAIM analysis. The Thin Layer Chromatography (TLC) plates and strip papers loaded with ODA were used to test the practical applications for sensing Al3+ and Zn2+ ions. Moreover, the probe has been used for live-cell imaging to detect Al3+ and Zn2+ ions in hepatoma C3A and human glioblastoma U87 cells.

Synthesis, structure and bioactivity of Ni2+ and Cu2+ acylhydrazone complexes

Two acylhydrazone complexes, bis{6-methyl-N'-[1-(pyrazin-2-yl-κN¹)ethylidene]nicotinohydrazidato-κ²N',O}nickel(II), [Ni(C₁₃H₁₂N₅O)₂], (I), and di-μ-azido-κ⁴N¹:N¹-bis({6-methyl-N'-[1-(pyrazin-2-yl-κN¹)ethylidene]nicotinohydrazidato-κ²N',O}nickel(II)), [Cu₂(C₁₃H₁₂N₅O)₂(N₃)₂], (II), derived from 6-methyl-N'-[1-(pyrazin-2-yl)ethylidene]nicotinohydrazide (HL) and azide salts, have been synthesized. HL acts as an N,N',O-tridentate ligand in both complexes. Complex (I) crystallizes in the orthorhombic space group Pbcn and has a mononuclear structure, the azide co-ligand is not involved in crystallization and the Ni²⁺ centre lies in a distorted {N₄O₂} octahedral coordination environment. Complex (II) crystallizes in the triclinic space group P-1 and is a centrosymmetric binuclear complex with a crystallographically independent Cu²⁺ centre coordinating to three donor atoms from the deprotonated L^- ligand and to two N atoms belonging to two bridging azide anions. The two- and one-dimensional supramolecular structures are constructed by hydrogen-bonding interactions in (I) and (II), respectively. The in vitro urease inhibitory evaluation revealed that complex (II) showed a better inhibitory activity, with the IC₅₀ value being 1.32±0.4 µM. Both complexes can effectively bind to bovine serum albumin (BSA) by 1:1 binding, which was assessed via tryptophan emission-quenching measurements. The bioactivities of the two complexes towards jack bean urease were also studied by molecular docking. The effects of the metal ions and the coordination environments in the two complexes on in vitro urease inhibitory activity are preliminarily discussed.

Copper(ii) complexes based on levofloxacin and 2N-donor ligands: synthesis, crystal structures and in vitro biological evaluation

The molecular structures and in vitro biological applications of two cationic copper(ii) complexes are reported.